This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Neuronova Ab. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Anne Schanzer
Introduction
Anne Schanzer is a prominent inventor based in Frankfurt am Main, Germany. She has made significant strides in the field of medical research, particularly in the treatment of neurological disorders. Her work focuses on innovative methods to influence central nervous system cells, which can lead to advancements in treating conditions such as Parkinson's disease.
Latest Patents
Anne Schanzer holds a patent for her invention titled "Treatment of Parkinson's disease with PDGF." This invention relates to methods of influencing central nervous system cells to produce progeny that are useful in treating CNS disorders. Specifically, it includes methods for exposing patients suffering from such disorders to a reagent that modulates the proliferation, migration, differentiation, and survival of central nervous system cells. These methods are designed to reduce at least one symptom of the disorder. She has 1 patent to her name.
Career Highlights
Throughout her career, Anne has demonstrated a commitment to advancing medical science. Her innovative approaches have garnered attention in the research community, and her work continues to inspire future developments in the treatment of CNS disorders.
Collaborations
Anne Schanzer collaborates with notable colleagues, including Kioumars Delfani and Ann Marie Janson. Their combined expertise contributes to the ongoing research and development of effective treatments for neurological conditions.
Conclusion
Anne Schanzer's contributions to the field of medical research, particularly in the treatment of Parkinson's disease, highlight her innovative spirit and dedication to improving patient outcomes. Her work exemplifies the impact that dedicated inventors can have on healthcare advancements.